Characteristics of the patients with flare and no flare within 2 years after stopping IS
| No Flare (n=74) | Flare (n=25) | p | |
|---|---|---|---|
| N (%) | N (%) | ||
| At time of Tapering start | |||
| AMS 1 year prior | 2.9±2.4 | 2.6±1.6 | 0.5 |
| Steroids | 38 (51.4%) | 16 (64.0%) | 0.27 |
| Dose (mg/day) | 5.3±2.3 | 5.4±1.8 | 0.92 |
| Anti-malarial | 45 (60.8%) | 15 (60.0%) | 0.94 |
| DNA positive | 19 (25.7%) | 7 (28.0%) | 0.82 |
| Low C3 or C4 | 26 (35.1%) | 10 (40.0%) | 0.66 |
| Either DNA positive or low C3/C4 | 34 (45.9%) | 15 (60.0%) | 0.25 |
| At time of IS stop | |||
| Steroids | 22 (29.7%) | 13 (52.0%) | 0.04 |
| Dose (mg/day) | 5.3±1.5 | 4.1±2.8 | 0.04 |
| Anti-malarial | 47 (63.5%) | 15 (60.0%) | 0.75 |
| DNA positive | 20 (27.0%) | 9 (37.5%) | 0.35 |
| Low C3 or C4 | 20 (27.0) | 13 (52.0%) | 0.02 |
| Either DNA positive or low C3/C4 | 31 (41.9%) | 17 (68.0%) | 0.04 |